反応式
[CH:1]1([CH2:6][C@H:7]([N:11]2[CH2:19][C:18]3[C:13](=[CH:14][CH:15]=[CH:16][C:17]=3[C:20]([F:23])([F:22])[F:21])[C:12]2=[O:24])[C:8]([OH:10])=O)[CH2:5][CH2:4][CH2:3][CH2:2]1.C(Cl)(=O)C(Cl)=O.[NH2:31][C:32]1[CH:36]=[CH:35][N:34]([CH2:37][CH2:38][OH:39])[N:33]=1.N1C(C)=CC=CC=1C>C(Cl)Cl.CN(C)C=O>[CH:1]1([CH2:6][C@H:7]([N:11]2[CH2:19][C:18]3[C:13](=[CH:14][CH:15]=[CH:16][C:17]=3[C:20]([F:23])([F:22])[F:21])[C:12]2=[O:24])[C:8]([NH:31][C:32]2[CH:36]=[CH:35][N:34]([CH2:37][CH2:38][OH:39])[N:33]=2)=[O:10])[CH2:5][CH2:4][CH2:3][CH2:2]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 0 °C
実験手順
A solution of (S)-3-cyclopentyl-2-(1-oxo-4-trifluoromethyl-1,3-dihydro-isoindol-2-yl)-propionic acid (50 mg, 0.15 mmol, prepared as in Example 1) in methylene chloride (5 mL) and N,N-dimethylformamide (1 drop) cooled to 0° C. was treated with a solution of oxalyl chloride in methylene chloride (2.0 M, 88 μL, 0.18 mmol) and stirred at 0° C. for 10 min. After this time, the reaction mixture was warmed to room temperature and then stirred for another 25 min. After this time, the reaction mixture was then concentrated in vacuo and the residue taken up in methylene chloride (2 mL) and added dropwise to a separate reaction flask containing a mixture of 2-(3-amino-pyrazol-1-yl)-ethanol (28 mg, 0.22 mmol) and 2,6-lutidine (32 μL, 0.29 mmol) in methylene chloride (5 mL) cooled to 0° C. The resulting reaction mixture was then allowed to warm to room temperature and stirred for 16 h. After such time, the reaction mixture was quenched with a saturated aqueous sodium bicarbonate solution (10 mL) and then extracted with methylene chloride (3×15 mL). The organic layers were then washed with a 1N aqueous hydrochloric acid solution (10 mL), dried over magnesium sulfate, filtered to remove the drying agent, and the filtrate concentrated in vacuo. The crude material was purified via automated flash chromatography (4 g silica gel column, 60-95% ethyl acetate/hexanes) to afford (S)-3-cyclopentyl-N-[1-(2-hydroxy-ethyl)-1H-pyrazol-3-yl]-2-(1-oxo-4-trifluoromethyl-1,3-dihydro-isoindol-2-yl)-propionamide (57 mg, 86%) as a white foam: [α]29D=−28.5°, (c=0.26, methylene chloride); HR-ES(+) m/e calcd for C22H25N4O3F3 [M+H]+ 451.1952, observed 451.1950; 1H NMR (300 MHz, DMSO-d6) δ ppm 10.91 (s, 1H), 8.01 (t, J=8.50 Hz, 2H), 7.69-7.81 (m, 1H), 7.56 (d, J=2.27 Hz, 1H), 6.40 (d, J=2.27 Hz, 1H), 4.97-5.13 (m, 2H), 4.85 (t, J=5.29 Hz, 1H), 4.71 (d, J=18.51 Hz, 1H), 4.02 (t, J=5.67 Hz, 2H), 3.69 (q, J=5.67 Hz, 2H), 0.99-2.12 (m, 11H).
後処理
- temperatureAfter this time, the reaction mixture was warmed to room temperature
- stirringstirred for another 25 min
- concentrationAfter this time, the reaction mixture was then concentrated in vacuo
- additionadded dropwise to a separate reaction flask
- additioncontaining
- temperaturecooled to 0° C
- customThe resulting reaction mixture
- temperatureto warm to room temperature
- stirringstirred for 16 h
- customAfter such time, the reaction mixture was quenched with a saturated aqueous sodium bicarbonate solution (10 mL)
- extractionextracted with methylene chloride (3×15 mL)
- washThe organic layers were then washed with a 1N aqueous hydrochloric acid solution (10 mL)
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- customto remove the drying agent
- concentrationthe filtrate concentrated in vacuo
- customThe crude material was purified
出典と根拠
- ORDレコード
- ord-b1b51d00501a47d98c4850a0327c29c6
- 出典データセット
- uspto-grants-2013_06
- 特許番号
- US08470866B2
関連ノート
読み込み中…